Literature DB >> 8405037

Drug use in pregnancy: a comparative appraisal of data collecting methods.

L T de Jong-van den Berg1, C M Waardenburg, F M Haaijer-Ruskamp, M N Dukes, H Wesseling.   

Abstract

We have compared the reliability of the information about drug therapy and pregnancy retrieved by interviewing patients with that distilled from pharmacy records. In the initial phase of each interview we used the internationally accepted open-ended technique, and extended this with an indication-oriented set of questions and then a set of specific drug-oriented questions. These data were then compared with those from pharmacy records on dispensing for the same patients during their pregnancy. The results suggest that if drug consumption during pregnancy is evaluated by interview, one should not restrict oneself to open-ended questions but should include indication-oriented and, when appropriate, drug-oriented questions. Such specific questions offer the opportunity of detecting the use of over-the-counter medication and of constructing drug use/complaint profiles. By contrast, pharmacy records will give better information in case of long recall periods and in patients with multiple and/or repeated drug use. Investigators should use the complementary elements of both techniques where appropriate.

Entities:  

Mesh:

Year:  1993        PMID: 8405037     DOI: 10.1007/bf00315343

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  14 in total

Review 1.  Agreement between questionnaire data and medical records. The evidence for accuracy of recall.

Authors:  S D Harlow; M S Linet
Journal:  Am J Epidemiol       Date:  1989-02       Impact factor: 4.897

2.  Investigating drug use in pregnancy. Methodological problems and perspectives.

Authors:  L T De Jong-van den Berg; P B Van den Berg; F M Haaijer-Ruskamp; M N Dukes; H Wesseling
Journal:  Pharm Weekbl Sci       Date:  1991-02-22

3.  Drug use in pregnancy: an overview of epidemiological (drug utilization) studies.

Authors:  M Bonati; R Bortolus; F Marchetti; M Romero; G Tognoni
Journal:  Eur J Clin Pharmacol       Date:  1990       Impact factor: 2.953

4.  Drug use in pregnancy: a preliminary report of the International co-operative Drug Utilization Study. Collaborative Group on Drug Use in Pregnancy.

Authors: 
Journal:  Pharm Weekbl Sci       Date:  1990-04-27

5.  Childbirth research data: medical records or women's reports?

Authors:  D Hewson; A Bennett
Journal:  Am J Epidemiol       Date:  1987-03       Impact factor: 4.897

6.  Drug prescribing during pregnancy. A controlled study of Tennessee Medicaid recipients.

Authors:  J C Brocklebank; W A Ray; C F Federspiel; W Schaffner
Journal:  Am J Obstet Gynecol       Date:  1978-10-01       Impact factor: 8.661

7.  Epidemiology of drugs taken by pregnant women: drugs that may affect the fetus adversely.

Authors:  J O Forfar; M M Nelson
Journal:  Clin Pharmacol Ther       Date:  1973 Jul-Aug       Impact factor: 6.875

8.  Prospective versus retrospective approach in the search for environmental causes of malformations.

Authors:  A Klemetti; L Saxén
Journal:  Am J Public Health Nations Health       Date:  1967-12

9.  Obtaining drug exposure histories during pregnancy.

Authors:  T W Bodendorfer; G G Briggs; J E Gunning
Journal:  Am J Obstet Gynecol       Date:  1979-10-15       Impact factor: 8.661

10.  Effect of questionnaire design on recall of drug exposure in pregnancy.

Authors:  A A Mitchell; L B Cottler; S Shapiro
Journal:  Am J Epidemiol       Date:  1986-04       Impact factor: 4.897

View more
  20 in total

Review 1.  Effect of over-the-counter drugs on the unborn child: what is known and how should this influence prescribing?

Authors:  S Kacew
Journal:  Paediatr Drugs       Date:  1999 Apr-Jun       Impact factor: 3.022

2.  How do we best detect toxic effects of drugs taken during pregnancy? A EuroMap paper.

Authors:  Jørn Olsen; Andrew Czeizel; Henrik Toft Sørensen; Gunnar Lauge Nielsen; Lolkje T W de Jong van den Berg; Lorentz M Irgens; Charlotte Olesen; Lars Pedersen; Helle Larsen; Rolv T Lie; Corinne S de Vries; Ulf Bergman
Journal:  Drug Saf       Date:  2002       Impact factor: 5.606

Review 3.  Case-population studies in pharmacoepidemiology.

Authors:  Dolors Capellà; Consuelo Pedrós; Xavier Vidal; Joan-Ramon Laporte
Journal:  Drug Saf       Date:  2002       Impact factor: 5.606

4.  Maternal recall of prescription medication use during pregnancy using a paper-based questionnaire: a validation study in the Netherlands.

Authors:  Marleen M H J van Gelder; Iris A L M van Rooij; Hermien E K de Walle; Nel Roeleveld; Marian K Bakker
Journal:  Drug Saf       Date:  2013-01       Impact factor: 5.606

5.  Validation of maternal recall of early pregnancy medication exposure using prospective diary data.

Authors:  Alexandra C Sundermann; Katherine E Hartmann; Sarah H Jones; Eric S Torstenson; Digna R Velez Edwards
Journal:  Ann Epidemiol       Date:  2016-12-09       Impact factor: 3.797

6.  Additional information from parental questionnaires and pharmacy records for registration of birth defects. EuroMAP-group.

Authors:  J Reefhuis; H E de Walle; L T de Jong-van den Berg; M C Cornel
Journal:  Eur J Epidemiol       Date:  2000-04       Impact factor: 8.082

7.  Identifying associations between maternal medication use and birth defects using a case-population approach: an exploratory study on signal detection.

Authors:  Linda de Jonge; Priscilla A Zetstra-van der Woude; H Jens Bos; Lolkje T W de Jong-van den Berg; Marian K Bakker
Journal:  Drug Saf       Date:  2013-11       Impact factor: 5.606

8.  Drug prescription in pregnancy: analysis of a large statutory sickness fund population.

Authors:  Veronika Egen-Lappe; Joerg Hasford
Journal:  Eur J Clin Pharmacol       Date:  2004-10-07       Impact factor: 2.953

9.  Effect of questionnaire structure on recall of drug utilization in a population of university students.

Authors:  Helena Gama; Sofia Correia; Nuno Lunet
Journal:  BMC Med Res Methodol       Date:  2009-06-29       Impact factor: 4.615

10.  Information on drug use in the elderly: a comparison of pharmacy, general-practitioner and patient data.

Authors:  E R Heerdink; H G Leufkens; C Koppedraaijer; A Bakker
Journal:  Pharm World Sci       Date:  1995-01-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.